Xiaozhen Zhao Selected Research

Xiaozhen Zhao Research Topics

Disease

6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2022 - 01/2018
6	Varicocele 10/2021 - 01/2016
3	Neoplasms (Cancer) 01/2022 - 07/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
2	Infections 01/2022 - 01/2020
2	Rheumatoid Arthritis 01/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 07/2015 - 06/2011
1	Carcinogenesis 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Intraoperative Complications 01/2021
1	Immunoglobulin G4-Related Disease 02/2020
1	Lupus Nephritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 11/2018
1	Human Influenza (Influenza) 11/2018
1	Serositis 10/2018
1	Leukopenia 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Vasculitis (Vasculitides) 05/2018
1	Systemic Vasculitis 01/2018
1	Aphthous Stomatitis (Aphthous Ulcer) 01/2018
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2018
1	Behcet Syndrome (Behcet's Syndrome) 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Erythema Nodosum 01/2018
1	Inflammation (Inflammations) 01/2018
1	AIDS-Related Complex (ARC) 01/2017
1	Disease Resistance 01/2017

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 06/2011
4	Polysaccharides (Glycans)IBA 10/2021 - 01/2016
3	Immunoglobulin G (IgG)IBA 01/2022 - 11/2018
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2019 - 01/2016
3	AutoantibodiesIBA 10/2018 - 01/2018
2	Interleukin-2 (IL2)IBA 01/2022 - 01/2020
2	AntibodiesIBA 01/2022 - 11/2018
2	Messenger RNA (mRNA)IBA 10/2021 - 06/2011
2	morpholinopropane sulfonic acid (MOPS)IBA 01/2019 - 01/2017
1	InterferonsIBA 09/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	AntigensIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	IronIBA 01/2022
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 12/2021
1	artenimol (dihydroartemisinin)IBA 12/2021
1	Long Noncoding RNAIBA 10/2021
1	Ion Channels (Ion Channel)IBA 10/2021
1	Purinergic Receptors (Receptors, Purine)IBA 10/2021
1	Therapeutic UsesIBA 10/2021
1	Inosine Monophosphate (IMP)IBA 01/2021
1	iguratimodIBA 02/2020
1	Pharmaceutical PreparationsIBA 02/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2020
1	TeaIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	HaptensIBA 11/2018
1	Immunoglobulins (Immunoglobulin)IBA 11/2018
1	Thrombospondin 1IBA 10/2018
1	Indicators and Reagents (Reagents)IBA 05/2018
1	anti-dsDNA autoantibodyIBA 05/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018
1	EnzymesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	CatalaseIBA 01/2017
1	Superoxide DismutaseIBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	ClaudinsIBA 01/2016
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2016
1	OccludinIBA 01/2016
1	CytokinesIBA 01/2016
1	Testosterone (Sustanon)FDA Link 01/2016
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2016
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2016
1	inhibin BIBA 01/2016
1	IntegrinsIBA 07/2015
1	integrin-linked kinaseIBA 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 07/2015
1	beta CateninIBA 06/2011
1	Fibronectins (Fibronectin)IBA 06/2011
1	VimentinIBA 06/2011
1	Cadherins (E-Cadherin)IBA 06/2011
1	alpha Catenin (alpha E-Catenin)IBA 06/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 02/2020
1	Immunotherapy 01/2022
1	Ligation 01/2021
1	Drug Therapy (Chemotherapy) 01/2018